Dorubin

Sobre este medicamento

Originator: Cerubidine by HIKMA pharmaceutical · Manufacturer: Drug International Pharma. Indication & Dosage: Dorubin (Daunorubicin Hydrochloride) is a prescription medicine used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and chronic myelogenous leukemia (CML). Daunorubicin Hydrochloride also works for Kaposi's sarcoma. Daunorubicin Hydrochloride is an anti-cancer (Antineoplastic or cytotoxic) chemotherapy drug. Daunorubicin Hydrochloride belongs to a class of drugs known as anthracycline antitumor antibiotic and works by slowing or stopping the growth of cancer cells. Dorubin is manufactured by Drug International Pharma Ltd. in Bangladesh. Daunorubicin Hydrochloride is given by injection into a vein by a health care professional. The dosage and treatment schedule are based on patient medical condition, body size, and response to treatment. Side Effects: The most common side effects of Daunorubicin Hydrochloride are: Nausea , vomiting , constipation , diarrhea , and loss of appetite may occur. The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.